Aarey Drugs & Pharmaceuticals Ltd.
NSE: AAREYDRUGS | BSE: 524412
₹79.35
₹1.50
(1.93%)
As on 15-Jun-2026IST
Market cap
₹224 Cr
Revenue (TTM)
₹472 Cr
P/E Ratio
56.4
P/B Ratio
1.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹5 Cr
-
ROE
3 %
-
ROCE
6.4 %
-
Industry P/E
41.12
-
EV/EBITDA
20.5
-
Debt to Equity
0
-
Book Value
₹51.7
-
EPS
₹1.6
-
Face value
10
-
Shares outstanding
28,354,303
10 Years Aggregate
CFO
₹1.48 Cr
EBITDA
₹62.53 Cr
Net Profit
₹50.82 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Aarey Drugs
| 17.3 | -13.1 | 21.7 | 43.5 | 36.1 | -- | -- |
|
BSE Healthcare
| 8.6 | 0.1 | 10.2 | 7.2 | 24.4 | 13.1 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Aarey Drugs
| 17.6 | -5.9 | 30.8 | -10.0 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Aarey Drugs
|
79.4 | 223.8 | 472.3 | 4.5 | 0.9 | 3 | 56.4 | 1.5 |
| 3,096.7 | 25,332.2 | 1,339.4 | 356.4 | 33.2 | 23.2 | 71.1 | 15.3 | |
| 427.0 | 16,314.6 | 2,268.6 | 150.1 | 10.6 | 5.4 | 91 | 4.2 | |
| 748.5 | 18,561.2 | 5,365.6 | 595.0 | 16.6 | 13.3 | 31.2 | 3.7 | |
| 991.4 | 15,800.7 | 8,279.6 | 397.8 | 9.9 | 6.4 | 39.7 | 2.2 | |
| 847.6 | 15,180.5 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 10.7 | 1.6 | |
| 1,623.4 | 18,619.6 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.2 | |
| 167.2 | 22,266.8 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.7 | |
| 453.5 | 18,274.1 | 3,738.7 | 316.7 | 12.5 | 7.5 | 57.7 | 3.8 | |
| 1,907.6 | 30,998.6 | 3,373.0 | 199.0 | 12.6 | 5.9 | 145.5 | 6.3 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Aarey Drugs
Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di... methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, glycols and glycol ethers, fiber intermediates, and acetates and esters, as well as industrial alcohols, ketones, amines, oleochemicals, intermediates, olefins, phosphates, fertilizers, monomers, and chemicals. It serves pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India. Read more
-
Incorporated
1990
-
Chairman
Mihir R Ghatalia
-
Managing Director
Mihir R Ghatalia
-
Group
Aarey
-
Headquarters
Thane, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Aarey Drugs
What is the current share price of Aarey Drugs & Pharmaceuticals Ltd Today?
The share price of Aarey Drugs & Pharmaceuticals Ltd is ₹79.35 (NSE) and ₹78.93 (BSE) as of 15-Jun-2026 IST. Aarey Drugs & Pharmaceuticals Ltd has given a return of 36.14% in the last 3 years.
What is the current PB & PE ratio of Aarey Drugs & Pharmaceuticals Ltd?
The P/E ratio of Aarey Drugs & Pharmaceuticals Ltd is 56.40 times as on 15-Jun-2026, a 37 premium to its peers’ median range of 41.12 times.
The P/B ratio of Aarey Drugs & Pharmaceuticals Ltd is 1.53 times as on 15-Jun-2026, a 60 discount to its peers’ median range of 3.87 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
23.84
|
0.71
|
|
2024
|
26.76
|
0.96
|
|
2023
|
15.93
|
0.52
|
|
2022
|
16.03
|
0.94
|
|
2021
|
8.33
|
0.56
|
What is the 52 Week High and Low of Aarey Drugs & Pharmaceuticals Ltd?
The 52-week high and low of Aarey Drugs & Pharmaceuticals Ltd are Rs 100.00 and Rs 50.31 as of 16-Jun-2026.
What is the market cap of Aarey Drugs & Pharmaceuticals Ltd?
Aarey Drugs & Pharmaceuticals Ltd has a market capitalisation of ₹ 224 Cr as on 15-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Aarey Drugs & Pharmaceuticals Ltd?
Before investing in Aarey Drugs & Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.